Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN62865905
ISRCTN62865905
Completed
未知

on-pharmacological management of breathlessness: a randomised controlled trial of different intensity training

Hull and East Yorkshire Hospitals NHS Trust (UK)0 sites40 target enrollmentMarch 5, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBreathlessness in patients with intrathoracic malignancyCancerMalignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

Overview

Phase
未知
Intervention
Not specified
Conditions
Breathlessness in patients with intrathoracic malignancy
Sponsor
Hull and East Yorkshire Hospitals NHS Trust (UK)
Enrollment
40
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20392515

Registry
who.int
Start Date
March 5, 2009
End Date
September 30, 2008
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hull and East Yorkshire Hospitals NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Intractable breathlessness resulting from primary or secondary malignant lung disease in the palliative setting where the underlying cause has been maximally treated
  • •2\. All identified reversible causes of the breathlessness have been treated if appropriate to do so, in the opinion of the attending clinician
  • •3\. Karnofsky Performance Status (KPS) greater than 40%
  • •4\. Aged greater than 18 years, either sex
  • •5\. Willingness to attend for breathlessness training
  • •6\. Ability to give informed consent
  • •7\. Expected prognosis of at least 3 months in the opinion of the attending clinician

Exclusion Criteria

  • •1\. Inability to give informed consent
  • •2\. Intercurrent illness or co\-morbidities making completion of the physiotherapy breathlessness course (PBC) course unlikely
  • •3\. Rapidly worsening breathlessness requiring urgent medical intervention
  • •4\. Palliative radiotherapy to chest in previous 4 weeks
  • •5\. Radical radiotherapy in previous 6 months
  • •6\. Chemotherapy or change in anti\-cancer hormone treatment in previous 2 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Better treatments for refractory breathlessness
ISRCTN32236160Kings College Hospital NHS Foundation Trust64
Completed
Not Applicable
Better management of breathlessness in the ICU (BreatheICU): A cross-sectional national clinician survey and consumer interview study.
ACTRN12622000701729Mr Leigh Rushworth160
Completed
Not Applicable
Opioids in the management of breathlessness in advanced heart failureChronic heart failureCirculatory SystemChronic Heart Failure
ISRCTN85268059Hull and East Yorkshire Hospitals NHS Trust (UK)48
Completed
Not Applicable
Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced DiseaseBreathlessnessCOPDCancerChronic Heart FailureInterstitial Lung Disease
NCT02622412Ludwig-Maximilians - University of Munich183
Completed
Not Applicable
Improving Management of Breathlessness in Patients With Lung CancerBreathlessnessDyspneaLung Cancer
NCT01937637Massachusetts General Hospital32